Carsten Müller‐Tidow

机构：German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Klinik und Poliklinik für Neurologie, University Hospital in Halle, Deutsches Konsortium für Translationale Krebsforschung, Martin Luther University Halle-Wittenberg, Heidelberg University · ORCID：0000-0002-7166-5232

发表论文 1201 篇 · 总被引 32595 次 · h-index 87

代表论文

• Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial (2026 · Nature Medicine · 被引 2)
• Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment (2026 · Cancer Cell)
• A distinct CAR-T cell phenotype mediates therapeutic response at limited doses (2026 · Nature Communications)
• In Silico Trial Simulation with Artificial Intelligence-Generated Synthetic Control Cohorts Reproduces Results of a Randomized Controlled Trial in Acute Myeloid Leukemia (2026 · medRxiv)
• Hierarchical classification of hematologic malignancies using epigenetic and genetic information (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial (2026 · Nature Medicine)